tetrahydropalmatine has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z; Wang, J; Yin, X; Zhang, J; Zhao, W | 1 |
| Liu, ZJ; Wang, J; Yin, XZ | 1 |
| Liu, Z; Wang, J; Yin, X | 1 |
3 other study(ies) available for tetrahydropalmatine and Liver Neoplasms
| Article | Year |
|---|---|
Combined Levo-tetrahydropalmatine and diphenyleneiodonium chloride enhances antitumor activity in hepatocellular carcinoma.
Topics: AMP-Activated Protein Kinases; Animals; Berberine Alkaloids; Carcinoma, Hepatocellular; Liver Neoplasms; Mice; Onium Compounds | 2022 |
[Levo-tetrahydropalmatine promotes apoptosis of human hepatocellular carcinoma through switching energy metabolism phenotype via upregulation of mitochondrial reactive oxygen species].
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Mitochondria; Phenotype; Reactive Oxygen Species; Up-Regulation | 2022 |
Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Topics: AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Diet, High-Fat; Lipid Metabolism; Liver; Liver Neoplasms; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Oleic Acid; Sirtuin 1; Sterol Regulatory Element Binding Protein 1 | 2023 |